A bismuth-copper bimetallic coordination nanomaterial, its preparation method and application
By combining bismuth-copper bimetallic nanomaterials with sonodynamic therapy and chemodynamic therapy, the problem of low efficiency of sonodynamic therapy in the tumor microenvironment has been solved, achieving the effect of efficiently killing tumor cells and activating the immune response.
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- HUNAN SHIZHUYUAN NON FERROUS METAL
- Filing Date
- 2026-01-07
- Publication Date
- 2026-05-26
AI Technical Summary
Existing sonodynamic therapy (SDT) is limited by the dual barriers of the tumor microenvironment in tumor treatment, resulting in low treatment efficiency and an inability to effectively kill cancer cells and activate the immune system.
A bismuth-copper bimetallic coordination nanomaterial was developed. Through the synergistic effect of sonodynamic therapy (SDT) and chemokinetic therapy (CDT), Cu2+ catalyzes a Fenton-like reaction in tumor endogenous H2O2 to generate highly toxic hydroxyl radicals, which are internalized into tumor cells via copper transporter protein (CTR1), inducing oligomerization of the mitochondrial enzyme DLAT and activating immunogenic cell death.
It achieves efficient generation of reactive oxygen species (ROS) under ultrasound stimulation, enhances the oxidative stress response of tumor cells, depletes the tumor's antioxidant barrier, directly kills tumor cells and activates the immune system, and effectively inhibits the proliferation of cancer cells.
Smart Images

Figure CN122075686A_ABST